Erratum : Correction to anthraquinone derivatives as potent inhibitors of c-met kinase and the extracellular signaling pathway (ACS Medicinal Chemistry Letters (2013) 4 (408-403) DOI: 10.1021/ml4000047);Anthraquinone derivatives as potent inhibitors of c-Met kinase and the extracellular signaling pathway

ACS Medicinal Chemistry Letters

Volumn 4, Issue 4, 2013, Pages 408-413

  Liang, Zhongjie ^a,b   Ai, Jing ^b   Ding, Xiao ^b   Peng, Xia ^b   Zhang, Dengyou ^b   Zhang, Ruihan ^b   Wang, Ying ^b   Liu, Fang ^b   Zheng, Mingyue ^b   Jiang, Hualiang ^b   Liu, Hong ^b   Geng, Meiyu ^b   Luo, Cheng ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Anthraquinone derivatives; binding affinity with HGF; c Met kinase inhibitors

Indexed keywords

0 TOLUIDINE; 2 METHYLANILINE; 2,2 DIMETHOXYBIPHENYL; 2,2 DIMETHYLBIPHENYL; 2,5 DIMETHYL 1,4 PHENYL; 2,5 DIMETHYLBENZENE 1,4 DIAMINE; 3,3 DIMETHYLBIPHENYL; 4,4 (ETHANE 1,2 DIYL)DIANILINE; 4,4 OXIDIANILINE; 4,4' METHYLENEDIANILINE; ACETIC ACID DERIVATIVE; ANILINE; ANTHRAQUINONE DERIVATIVE; BENZIDINE; BIPHENYL; CRIZOTINIB; CYCLOHEXANE CARBONYL; ENZYME INHIBITOR; METHYLENEBIS(4,1 PHENYL); OXYBIS(4,1 PHENYL); PHENYL; PYRIMIDIN 2 YL; TERT BUTOXYCARBONYL; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG POTENCY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXTRACELLULAR SPACE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; IC 50; PARACRINE SIGNALING; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE;

EID: 84876226738     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml500510q     Document Type: Erratum

References (20)

1. Yap, T. A.; de Bono, J. S. Targeting the HGF/c-Met axis: State of play Mol. Cancer Ther. 2010, 9 (5) 1077-9
2. Liu, X.; Newton, R. C.; Scherle, P. A. Developing c-MET pathway inhibitors for cancer therapy: Progress and challenges Trends Mol. Med. 2010, 16 (1) 37-45
3. Liu, X.; Newton, R. C.; Scherle, P. A. Development of c-MET pathway inhibitors Expert Opin. Invest. Drugs 2011, 20 (9) 1225-41
4. Gherardi, E.; Birchmeier, W.; Birchmeier, C.; Woude, G. V. Targeting MET in cancer: Rationale and progress Nat. Rev. Cancer 2012, 12 (2) 89-103
5. Liang, Z.; Ding, X.; Ai, J.; Kong, X.; Chen, L.; Luo, C.; Geng, M.; Liu, H.; Chen, K.; Jiang, H. Discovering potent inhibitors against c-Met kinase: Molecular design, organic synthesis and bioassay Org. Biomol. Chem. 2012, 10, 421-30
6. Zhang, D.; Ai, J.; Liang, Z.; Li, C.; Peng, X.; Ji, Y.; Jiang, H.; Geng, M.; Luo, C.; Liu, H. Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors Bioorg. Med. Chem. 2012, 20 (17) 5169-80
7. Liu, X.; Newton, R. C.; Scherle, P. A. Development of c-MET pathway inhibitors Expert Opin. Invest. Drugs 2011, 20 (9) 1225-41
8. Underiner, T. L.; Herbertz, T.; Miknyoczki, S. J. Discovery of small molecule c-Met inhibitors: Evolution and profiles of clinical candidates Anti-Cancer Agents Med. Chem. 2010, 10 (1) 7-27
9. Okamoto, W.; Okamoto, I.; Tanaka, K.; Hatashita, E.; Yamada, Y.; Kuwata, K.; Yamaguchi, H.; Arao, T.; Nishio, K.; Fukuoka, M.; Janne, P. A.; Nakagawa, K. TAK-701, a humanized monoclonal antibody to hepatocyte growth factor, reverses gefitinib resistance induced by tumor-derived HGF in non-small cell lung cancer with an EGFR mutation Mol. Cancer Ther. 2010, 9 (10) 2785-92
10. Underiner, T. L.; Herbertz, T.; Miknyoczki, S. J. Discovery of small molecule c-Met inhibitors: Evolution and profiles of clinical candidates Anti-Cancer Agents Med. Chem. 2010, 10 (1) 7-27
11. Cui, J. J.; Tran-Dube, M.; Shen, H.; Nambu, M.; Kung, P. P.; Pairish, M.; Jia, L.; Meng, J.; Funk, L.; Botrous, I.; McTigue, M.; Grodsky, N.; Ryan, K.; Padrique, E.; Alton, G.; Timofeevski, S.; Yamazaki, S.; Li, Q.; Zou, H.; Christensen, J.; Mroczkowski, B.; Bender, S.; Kania, R. S.; Edwards, M. P. Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK) J. Med. Chem. 2011, 54 (18) 6342-63
12. Xie, Q. Q.; Xie, H. Z.; Ren, J. X.; Li, L. L.; Yang, S. Y. Pharmacophore modeling studies of type I and type II kinase inhibitors of Tie2 J. Mol. Graphics Modell. 2009, 27 (6) 751-8
13. Li, H. F.; Lu, T.; Zhu, T.; Jiang, Y. J.; Rao, S. S.; Hu, L. Y.; Xin, B. T.; Chen, Y. D. Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas Eur. J. Med. Chem. 2009, 44 (3) 1240-9
14. Zou, J.; Xie, H. Z.; Yang, S. Y.; Chen, J. J.; Ren, J. X.; Wei, Y. Q. Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2 J. Mol. Graphics Modell. 2008, 27 (4) 430-8
15. Xiang, M.; Cao, Y.; Fan, W.; Chen, L.; Mo, Y. Computer-aided drug design: Lead discovery and optimization Comb. Chem. High Throughput Screening 2012, 15 (4) 328-37
16. Liang, Z.; Zhang, D.; Ai, J.; Chen, L.; Wang, H.; Kong, X.; Zheng, M.; Liu, H.; Luo, C.; Geng, M.; Jiang, H.; Chen, K. Identification and synthesis of N′-(2-oxoindolin-3-ylidene)hydrazide derivatives against c-Met kinase Bioorg. Med. Chem. Lett. 2011, 21 (12) 3749-54
17. Rickert, K. W.; Patel, S. B.; Allison, T. J.; Byrne, N. J.; Darke, P. L.; Ford, R. E.; Guerin, D. J.; Hall, D. L.; Kornienko, M.; Lu, J.; Munshi, S. K.; Reid, J. C.; Shipman, J. M.; Stanton, E. F.; Wilson, K. J.; Young, J. R.; Soisson, S. M.; Lumb, K. J. Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met J. Biol. Chem. 2011, 286 (13) 11218-25
18. Zagotto, G.; Sissi, C.; Lucatello, L.; Pivetta, C.; Cadamuro, S. A.; Fox, K. R.; Neidle, S.; Palumbo, M. Aminoacyl-anthraquinone conjugates as telomerase inhibitors: Synthesis, biophysical and biological evaluation J. Med. Chem. 2008, 51 (18) 5566-74
19. Morier-Teissier, E.; Boitte, N.; Helbecque, N.; Bernier, J. L.; Pommery, N.; Duvalet, J. L.; Fournier, C.; Hecquet, B.; Catteau, J. P.; Henichart, J. P. Synthesis and antitumor properties of an anthraquinone bisubstituted by the copper chelating peptide Gly-Gly-L-His J. Med. Chem. 1993, 36 (15) 2084-90
20. Zembower, D. E.; Kam, C. M.; Powers, J. C.; Zalkow, L. H. Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin G J. Med. Chem. 1992, 35 (9) 1597-605